Evidence map · BAT · heart failure
BAT for heart failure: what the research shows
Baroreflex activation therapy for heart failure. 163 papers from 1990 to 2026, including 8 meta-analyses, 3 systematic reviews and 7 randomised controlled trials. Each study below links to its source.
163Papers in the corpus
8Meta-analyses
7Randomised controlled trials
19Open-access papers
Study design
Jev labels40 papers have no confident study-design label yet. Labels are AI-classified by Jev: advisory, not clinician-reviewed.
Papers over time
by publication year* 2025–26 is still in progress, so its count is incomplete.
Most-cited trials and reviews
by citations- 1
Baroreflex Activation Therapy for the Treatment of Heart Failure With a Reduced Ejection Fraction.
- 2
Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
- 3
Baroreflex activation therapy for the treatment of heart failure with a reduced ejection fraction: safety and efficacy in patients with and without cardiac resynchronization therapy.
- 4
Baroreflex activation therapy with the Barostim™ device in patients with heart failure with reduced ejection fraction: a patient level meta-analysis of randomized controlled trials.
- 5
Baroreflex activation therapy for the treatment of heart failure with reduced ejection fraction in patients with and without coronary artery disease.
- 6
Surgical Experience and Long-term Results of Baroreflex Activation Therapy for Heart Failure With Reduced Ejection Fraction.
- 7
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
- 8
Updates on Baroreflex Activation Therapy and Vagus Nerve Stimulation for Treatment of Heart Failure With Reduced Ejection Fraction.
Recent trials and reviews
last 3 years- 1
Network meta-analysis on efficacy of nerve stimulation or modulation in patients with heart failure.
- 2
Phenotype characterization of heart failure with preserved ejection fraction in medical device and surgical trials.
- 3
Baroreflex activation therapy in patients with heart failure and a reduced ejection fraction: Long-term outcomes.
- 4
Non-pharmacologic autonomic neuromodulation for treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.
- 5
Baroreflex activation therapy for heart failure with reduced ejection fraction: A comprehensive systematic review and meta-analysis.
Decision support only. This page summarises published literature; it is not medical advice or a recommendation for any patient. Study designs and topic labels are AI-classified by Jev: advisory, not clinician-reviewed. Abstracts are not reproduced here: follow the links to read each source. Data snapshot 2026-09-25.